Cite
Modest DP, Karthaus M, Fruehauf S, et al. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in . J Clin Oncol. 2021;40(1):72-82doi: 10.1200/JCO.21.01332.
Modest, D. P., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., König, A. O., Fischer von Weikersthal, L., Caca, K., Kretzschmar, A., Goekkurt, E., Haas, S., Kurreck, A., Stahler, A., Held, S., Jarosch, A., Horst, D., Reinacher-Schick, A., Kasper, S., Heinemann, V., Stintzing, S., & Trarbach, T. (2022). Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 72-82. https://doi.org/10.1200/JCO.21.01332
Modest, Dominik Paul, et al. "Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in ." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 40,1 (2022): 72-82. doi: https://doi.org/10.1200/JCO.21.01332
Modest DP, Karthaus M, Fruehauf S, Graeven U, Müller L, König AO, Fischer von Weikersthal L, Caca K, Kretzschmar A, Goekkurt E, Haas S, Kurreck A, Stahler A, Held S, Jarosch A, Horst D, Reinacher-Schick A, Kasper S, Heinemann V, Stintzing S, Trarbach T. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in . J Clin Oncol. 2022 Jan 01;40(1):72-82. doi: 10.1200/JCO.21.01332. Epub 2021 Sep 17. PMID: 34533973; PMCID: PMC8683209.
Copy
Download .nbib